You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XL184

Showing 1 - 25 of 127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)

Active, not recruiting
  • Medullary Thyroid Cancer
  • Cabozantinib (XL184) 140 mg
  • +3 more
  • St. Leonards, New South Wales, Australia
  • +49 more
Jan 23, 2023

Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory

Active, not recruiting
Has Results
  • Metastatic Ewing Sarcoma
  • +9 more
  • Cabozantinib S-malate
  • Laboratory Biomarker Analysis
  • Bordeaux, France
  • +10 more
Nov 26, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Prostate Cancer Trial in Boston (Cabozantinib, Abiraterone)

Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 5, 2021

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jun 13, 2023

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

Not yet recruiting
  • Locally Advanced Adrenal Cortical Carcinoma
  • +4 more
  • Atezolizumab
  • +5 more
  • Atlanta, Georgia
  • +1 more
Aug 17, 2023

NF1, Neurofibromatosis, Plexiform Neurofibromas Trial in United States (Cabozantinib)

Active, not recruiting
  • NF1
  • +2 more
  • Los Angeles, California
  • +11 more
Jan 13, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • San Francisco, California
  • +4 more
Nov 24, 2023

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
  • +3 more
  • Cabozantinib S-malate
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 8, 2022

Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Cabozantinib S-malate
  • +2 more
  • La Jolla, California
  • +19 more
Dec 14, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Boston (Cabozantinib)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Boston, Massachusetts
  • +1 more
Jul 13, 2022

Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

Recruiting
  • Urothelial Cancer
  • Niraparib plus Cabozantinib
  • Barcelona, Cataluña, Spain
  • +10 more
Feb 8, 2022

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Atezolizumab
  • Cabozantinib S-malate
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Mar 11, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
Has Results
  • Glioblastoma Multiforme
  • +3 more
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

Meningioma Trial in Miami (Cabozantinib)

Recruiting
  • Meningioma
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
Jun 17, 2022

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
Has Results
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022